Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation

Molecular and Cellular Biology

Volumn 17, Issue 5, 1997, Pages 2353-2359

  Cultraro, Constance M ^a   Bino, Tamar ^a   Segal, Shoshana ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL NAVAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HEXAMETHYLENEBISACETAMIDE; ONCOPROTEIN; REGULATOR PROTEIN; ZINC;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; ERYTHROLEUKEMIA CELL; GENE SWITCHING; GROWTH INHIBITION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MURINAE;

EID: 0030906519     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.5.2353     Document Type: Article

References (70)

1. Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
2. Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423-426.
3. Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383-390.
4. Ayer, D. E., and R. N. Eisenman. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7:2110-2119.
5. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
6. Ayer, D. E., C. D. Laherty, Q. A. Lawrence, A. P. Armstrong, and R. N. Eisenman. 1996. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16:5772-5781.
7. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
8. Bar-Ner, M., L. T. Messing, C. M. Cultraro, M. J. Birrer, and S. Segal. 1992. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:183-190.
9. Bello-Fernandez, C., G. Packham, and J. L. Clevland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
10. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
11. Blackwood, E. M., B. Luscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71-80.
12. Cerni, C., K. Bousset, C. Seelos, H. Burkhardt, M. Henriksson, and B. Luscher. 1995. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11:587-596.
13. Chen, J., T. Willingham, L. R. Margraf, N. Schreiber-Agus, R. A. DePinho, and P. D. Nisen. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nat. Med. 1:638-643.
14. Chin, L., N. Schreiber-Agus, I. Pellicer, K. Chen, H. Lee, M. Dudast, C. Cordon-Cardo, and R. A. DePinho. 1995. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sci. USA 92:8488-8492.
15. Cogliati, T., B. K. Dunn, M. Bar-Ner, C. M. Cultraro, and S. Segal. 1993. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells. Oncogene 8:1263-1268.
16. Coppola, J. A., and M. D. Cole. 1986. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320:760-763.
17. Cowell, I. G. 1994. Repression versus activation in the control of gene transcription. Trends Biochem. Sci. 19:38-42.
18. Crouch, D. H., C. Lang, and D. A. F. Gillespie. 1990. The leucine zipper domain of avian c-Myc is required for transformation and autoregulation. Oncogene 5:683-689.
19. Cultraro, C. M., T. Cogliati, L. E. Hearing, and S. Segal. 1996. Basic mutant Max reverses a c-Myc block to differentiation. Oncol. Rep. 3:141-146.
20. Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic methods in molecular biology. Elsevier Science Publishing Co., New York, N.Y.
21. Delgado, M. D., A. Lerga, M. Canelles, M. T. Gomez-Casares, and J. Leon. 1995. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10:1659-1665.
22. Dmitrovsky, E., W. M. Kuehl, G. F. Hollis, I. R. Kirsch, T. P. Bender, and S. Segal. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322:748-750.
23. Dube, S. K., G. Gaedicke, G. Kluge, N. Weimann, B. J. Melderis, H. Steinheider, G. Crozier, H. Beckmann, and W. Ostertag. 1974. Hemoglobin-synthesizing mouse and human erythroleukemic cell lines as model systems for the study of differentiation and control of gene expression, p. 99-135. In W. Nakar, T. Ono, T. Suigimura, and H. Sugano (ed.), Differentiation and control of malignancy in tumor cells. University of Tokyo Press, Tokyo, Japan.
24. Dunn, B. K., T. Cogliati, C. M. Cultraro, M. Bar-Ner, and S. Segal. 1994. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells. Cell Growth Differ. 5:847-854.
25. Edelhoff, S., D. E. Ayer, A. S. Zervos, E. Steingrimsson, N. A. Jenkins, N. G. Copeland, R. N. Eisenman, R. Brent, and C. M. Disteche. 1994. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9:665-668.
26. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the α-prothymosin gene. EMBO J. 10:133-141.
27. 1 arrest. Nature 313:597-600.
28. 1. Mol. Cell. Biol. 8:1614-1624.
29. Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935-2939.
30. Harper, S. E., Y. Qiu, and P. Sharp. 1996. Sin3 corepressor function in Myc-induced transcription and transformation. Proc. Natl. Acad. Sci. USA 93:8536-8540.
31. Henriksson, M., and G. Luscher. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Cancer Res. 68:110-182.
32. Hurlin, P. J., K. P. Foley, D. E. Ayer, R. N. Eisenman, D. Hanahan, and J. M. Arbeit. 1995. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487-2501.
33. Hurlin, P. J., C. Queva, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14:5646-5659.
34. Kaczmarek, L., J. K. Hyland, R. Watt, M. Rosenberg, and R. Baserga. 1985. Microinjected c-myc as a competence factor. Science 228:1313-1315.
35. Kahn, S. M., W. Jiang, C. Borner, K. O'Driscoll, and I. B. Weinstein. 1990. Construction of defined deletion mutants by thermal cycled fusion: applications to protein kinase C. Tech. J. Methods Cell Mol. Biol. 2:27-30.
36. Kato, G., W. M. F. Lee, L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81-92.
37. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
38. Klinken, P. S., K. L. Holmes, H. C. Morse, and S. S. Thorgeirsson. 1988. Transcriptional and post-transcriptional regulation of c-myc and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO. Exp. Cell Res. 178:185-198.
39. Koskinen, P. J., D. E. Ayer, and R. N. Eisenman. 1995. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ. 6:623-629.
40. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429.
41. Lachman, H. M., and A. I. Skoultchi. 1984. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature 510:592-594.
42. Lahoz, E. G., L. Xu, N. Schreiber-Agus, and R. A. DePinho. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl. Acad. Sci. USA 91:5503-5507.
43. Larsson, L., M. Pettersson, F. Oberg, K. Nilsson, and B. Luscher. 1994. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9:1247-1252.
44. Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405-408.
45. Littlewood, T. D., B. Amati, H. Land, and G. I. Evan. 1992. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7:1785-1792.
46. Lymboussaki, A., A. Kaipainen, E. Hatva, I. Vastrik, L. Jeskanen, M. Jalkanen, S. Werner, R. Stenback, and R. Alitalo. 1996. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br. J. Cancer 73:1347-1355.
47. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
48. Marks, P. A., V. M. Richon, J. Kiyokawa, and R. A. Rifkind. 1994. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc. Natl. Acad. Sci. USA 91:10251-10254.
49. Mechti, N., M. Piechaczyk, J. Blanchard, L. Marty, A. Bonnieu, P. Jeanteur, and B. Lebleu. 1986. Transcriptional and posttranscriptional regulation of c-myc expression during differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res. 14:9653-9666.
50. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527-2535.
51. Min, S., and E. J. Taparowsky. 1992. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation. Oncogene 7:1531-1540.
52. Mukherjee, B., S. D. Morgenbesser, and R. A. DePinho. 1992. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev. 6:1480-1492.
53. Nepveu, A., K. B. Marcu, A. I. Skoultchi, and H. M. Lachman. 1987. Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. Genes Dev. 1:938-945.
54. Pena, A., C. D. Reddy, S. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and K. J. Soprano. 1993. Regulation of human ornithine decarboxylase expression by the c-Myc:Max protein complex. J Biol. Chem. 268: 27277-27285.
55. Prendergast, G. C., R. Hopewell, R. J. Gorham, and E. B. Ziff. 1992. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. Genes Dev. 6:2429-2439.
56. Prendergast, G. C., D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65:395-407.
57. Prochownik, E. V., and J. Kukowska. 1986. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 322:848-850.
58. 1 progression in murine erythroleukemia cells. Mol. Cell. Biol. 8:3683-3695.
59. Rao, G., L. Alland, P. Guida, N. Schreiber-Agus, K. Chen, L. Chin, J. M. Rochelle, M. F. Seldin, A. I. Skoultchi, and R. A. DePinho. 1996. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression domain of the Myc antagonist Mxi1. Oncogene 12:1165-1172.
60. Reddy, C. D., P. Dasgupta, P. Saikumar, H. Dudek, F. Rauscher, and E. P. Reddy. 1992. Mutational analysis of Max: role of basic, helix-loop-helix/feucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Oncogene 7:2085-2092.
61. Roussel, M. F., R. A. Ashmun, C. J. Sherr, R. N. Eisenman, and D. E. Ayer. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol. 16:2796-2801.
62. Roy, B., and D. Reisman. 1995. Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells. Cell Biol. Int. 19:307-313.
63. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
64. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates Anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor Sin3. Cell 80:777-786.
65. Shapiro, D. N., V. Valentine, L. Eagle, X. Yin, S. W. Morris, and E. V. Prochownik. 1994. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-25. Genomics 23:282-285.
66. Spotts, G. D., and S. R. Hann. 1990. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 10:3952-3964.
67. Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of region in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
68. Vastrik, I., A. Kaipainen, T. Penttila, A. Lymboussakis, R. Alitalo, M. Parvinen, and K. Alitalo. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol. 128:1197-1208.
69. Wagner, A. J., C. Meyers, A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879-883.
70. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.